2025-524856-73-00已完成1 期
A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of obesity
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 26
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Trial Information System - TISL
Scientific
F. Hoffmann-La Roche AG
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A study of the safety, absorption and effects of investigational drug ARV-102 in patients with Parkinson's disease.2024-516888-84-00Arvinas Operations Inc.44
招募中
1 期
A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers.2025-523328-31-00Almirall S.A.93
已完成
1 期
A Study to Evaluate the Safety and Tolerability of JNJ-77730614 When Given as Single and Multiple Doses to Healthy Participants to Assess How Long JNJ 77730614 Stays in the Body (Pharmacokinetics) and How the Body Responds to it (Pharmacodynamics)2023-505684-36-00Janssen - Cilag International92
招募中
1 期
A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants2025-524310-28-00Quralis Corp.48
招募中
1 期
A study to investigate the safety, the amount that reaches the bloodstream and the effects on the body of JNJ-64619178 in people with advanced cancers2024-515254-24-00Janssen Cilag International74